Sleeve resection for malignant lung disease offers a 30% 5-year survival rate, preserving lung function. This lung-sparing surgery is recommended for specific bronchus tumors when pneumonectomy is not feasible.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: